NCT03566979View on ClinicalTrials.gov

Efficacy and Safety Study of a Test Naproxen Sodium 220mg Tablet in Postoperative Dental Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

501

Participants

Timeline

Start Date

August 13, 2018

Primary Completion Date

March 26, 2019

Study Completion Date

April 15, 2019

Conditions
Post-operative Dental Pain
Interventions
DRUG

Test naproxen sodium tablet

Single dose of 2 test naproxen sodium 220 mg tablets

DRUG

Commercial naproxen sodium tablet

Single dose of 2 naproxen sodium 220 mg tablets

DRUG

Commercial naproxen sodium liquid gels capsule

Single dose of 2 naproxen sodium 220 mg liquid gel capsules

DRUG

Placebo tablet

2 placebo tablets

Trial Locations (1)

84107

JBR Clinical Research, Salt Lake City

All Listed Sponsors
lead

Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division

INDUSTRY

NCT03566979 - Efficacy and Safety Study of a Test Naproxen Sodium 220mg Tablet in Postoperative Dental Pain | Biotech Hunter | Biotech Hunter